Press Releases

    • December 17, 2020

    Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT™ Non-Invasive, Daily-Wear Adhesive Glucose Monitor

    Loughborough, England – December 17, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    November 17, 2020

    Nemaura Medical Launches BEAT™diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website

    Loughborough, England – November 17, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more
    November 16, 2020

    Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update

    Loughborough, England – November 16, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more
    October 22, 2020

    Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020

    Loughborough, England – October 22, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more
    September 21, 2020

    Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products

    Clinically proven app from Healthimation LLC, to be paired with Company’s proBEAT™ non-invasive CGM system solution to offer convenient...

    Read more
    September 18, 2020

    Nemaura Medical Appoints Justin Mclarney as Chief Finance Officer

    Loughborough, England – September 18 , 2020 (BusinessWire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical...

    Read more
    September 3, 2020

    Nemaura Medical to Provide US proBEAT™ launch update at The LD 500 Virtual Conference

    Loughborough, England, September 03, 2020 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused...

    Read more
    August 19, 2020

    Nemaura Medical issues Presentation Pertaining to the use of Continuous Glucose Monitoring in COVID-19 Patients

    Loughborough, England, August 19, 2020 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused...

    Read more
    August 17, 2020

    Nemaura Medical Reports Results and Provides Business Update for the First Quarter Ended June 30, 2020

    Loughborough, England, August 17, 2020 – Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a...

    Read more
    July 27, 2020

    Nemaura Enters into Letter of Intent to Acquire Healthimation, LLC to Augment proBEAT™ Launch in the U.S.

    Loughborough, England, July 27, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    Read more